Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Torben Bjerregaard Larsen(Aalborg University), Gregory Y.H. Lip(University of Liverpool)
Cited by 442
Related Papers
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
|Health Technology Assessment|2005|432
Microparticles and cardiovascular diseases
|Annals of Medicine|2019|54
Prevalence of Heart Failure and Atrial Fibrillation in Minority Ethnic Subjects: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
|PLoS ONE|2011|43
Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis
|Journal of Clinical Medicine|2020|35
Accelerometer-derived physical activity and the risk of death, heart failure, and stroke in patients with atrial fibrillation: a prospective study from UK Biobank
|British Journal of Sports Medicine|2024|18